Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.

Ky B, Liu T, Margulies KB, Mitchell JD, Haas NB, Gareen IF, Thangarajah M, Sicks JD, Domenico C, Narayan VK, Smith AM, Wilcox NS, Mittal K, Rhee JW, Armenian SH, Saphner T, Paul AK, Gartrell BA, Zaha VG, Anari F, Wong RL, Townsend RR, Wagner LI

Open source

DOI: 10.1161/hypertensionaha.125.26016
Published: 2026 Jul
Container: Hypertension (Dallas, Tex. : 1979)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/hypertensionaha.125.26016,
  title = {Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.},
  author = {Ky B and Liu T and Margulies KB and Mitchell JD and Haas NB and Gareen IF and Thangarajah M and Sicks JD and Domenico C and Narayan VK and Smith AM and Wilcox NS and Mittal K and Rhee JW and Armenian SH and Saphner T and Paul AK and Gartrell BA and Zaha VG and Anari F and Wong RL and Townsend RR and Wagner LI},
  year = {2026},
  journal = {Hypertension (Dallas, Tex. : 1979)},
  doi = {10.1161/hypertensionaha.125.26016},
  url = {https://doi.org/10.1161/hypertensionaha.125.26016}
}

RIS

TY  - JOUR
TI  - Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.
AU  - Ky B
AU  - Liu T
AU  - Margulies KB
AU  - Mitchell JD
AU  - Haas NB
AU  - Gareen IF
AU  - Thangarajah M
AU  - Sicks JD
AU  - Domenico C
AU  - Narayan VK
AU  - Smith AM
AU  - Wilcox NS
AU  - Mittal K
AU  - Rhee JW
AU  - Armenian SH
AU  - Saphner T
AU  - Paul AK
AU  - Gartrell BA
AU  - Zaha VG
AU  - Anari F
AU  - Wong RL
AU  - Townsend RR
AU  - Wagner LI
PY  - 2026
JO  - Hypertension (Dallas, Tex. : 1979)
DO  - 10.1161/hypertensionaha.125.26016
UR  - https://doi.org/10.1161/hypertensionaha.125.26016
ER  -

APA

B, K., T, L., KB, M., JD, M., NB, H., IF, G., M, T., JD, S., C, D., VK, N., AM, S., NS, W., K, M., JW, R., SH, A., T, S., AK, P., BA, G., VG, Z., F, A., RL, W., RR, T., & LI, W. (2026). Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.. Hypertension (Dallas, Tex. : 1979). https://doi.org/10.1161/hypertensionaha.125.26016

Source records

pubmed · retrieved 2026-09-27T15:36:15.630Z